UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

CC chemokine receptor small molecule antagonists in the treatment of rheumatoid arthritis and other diseases: a current view

Current topics in medicinal chemistry, 2010-09, Vol.10 (13), p.1250-1267

2010

Volltextzugriff (PDF)

Small molecule chemokine mimetics suggest a molecular basis for the observation that CXCL10 and CXCL11 are allosteric ligands of CXCR3

British journal of pharmacology, 2012-06, Vol.166 (3), p.912-923

2012

Volltextzugriff (PDF)

Discovery of 2-Hydroxy-N,N-dimethyl-3-{2-[[(R)-1-(5- methylfuran-2-yl)propyl]amino]-3,4-dioxocyclobut-1-enylamino}benzamide (SCH 527123): A Potent, Orally Bioavailable CXCR2/CXCR1 Receptor Antagonist

Journal of medicinal chemistry, 2006-12, Vol.49 (26), p.7603-7606

2006

Volltextzugriff (PDF)

Identification of CXCR3 receptor agonists in combinatorial small-molecule libraries

Biochemical and biophysical research communications, 2006-10, Vol.349 (1), p.221-228

2006

Volltextzugriff (PDF)

3,4-Diamino-2,5-thiadiazole-1-oxides as potent CXCR2/CXCR1 antagonists

Bioorganic & medicinal chemistry, 2008, Vol.18 (1), p.228-231

2008

Volltextzugriff (PDF)

Synthesis and structure–activity relationships of new disubstituted phenyl-containing 3,4-diamino-3-cyclobutene-1,2-diones as CXCR2 receptor antagonists

Bioorganic & medicinal chemistry, 2008-03, Vol.18 (6), p.1864-1868

2008

Volltextzugriff (PDF)

Chemokine receptors as targets in medicinal chemistry and drug discovery

Current topics in medicinal chemistry, 2010-09, Vol.10 (13), p.1249

2010

Volltextzugriff (PDF)

C(4)-alkyl substituted furanyl cyclobutenediones as potent, orally bioavailable CXCR2 and CXCR1 receptor antagonists

Bioorganic & medicinal chemistry letters, 2007-07, Vol.17 (13), p.3778-3783

2007

Volltextzugriff (PDF)

Novel Pyrrolidine Ureas as C−C Chemokine Receptor 1 (CCR1) Antagonists

Journal of medicinal chemistry, 2009-03, Vol.52 (5), p.1295-1301

2009

Volltextzugriff (PDF)

Synthesis and structure–activity relationships of 3,4-diaminocyclobut-3-ene-1,2-dione CXCR2 antagonists

Bioorganic & medicinal chemistry letters, 2006-08, Vol.16 (15), p.4107-4110

2006

Volltextzugriff (PDF)

To Market, To Market—2013

Annual Reports in Medicinal Chemistry, 2014, Vol.49, p.437-508

2014

Volltextzugriff (PDF)

Novel pyrrolidine heterocycles as CCR1 antagonists

Bioorganic & medicinal chemistry letters, 2010-09, Vol.20 (18), p.5477-5479

2010

Volltextzugriff (PDF)

Synthesis and structure–activity relationships of heteroaryl substituted-3,4-diamino-3-cyclobut-3-ene-1,2-dione CXCR2/CXCR1 receptor antagonists

Bioorganic & medicinal chemistry, 2008-02, Vol.18 (4), p.1318-1322

2008

Volltextzugriff (PDF)

Diaminocyclobutenediones as potent and orally bioavailable CXCR2 receptor antagonists: SAR in the phenolic amide region

Bioorganic & medicinal chemistry letters, 2009-08, Vol.19 (15), p.4446-4449

2009

Volltextzugriff (PDF)

n-Pentenyl Glycosides in Organic Chemistry: A Contemporary Example of Serendipity

Synlett, 1992, Vol.1992 (12), p.927-942

1992

Volltextzugriff (PDF)

n-Pentenyl Mannoside Precursors for Synthesis of the Nonamannan Component of High Mannose Glycoproteins

Journal of organic chemistry, 1994-08, Vol.59 (16), p.4443-4449

1994

Volltextzugriff (PDF)

Editorial [Hot topic: Chemokine Receptors as Targets in Medicinal Chemistry and Drug Discovery (Guest Editors: J. Robert Merritt and Maria Webb)]

Current topics in medicinal chemistry, 2010-09, Vol.10 (13), p.1249-1249

2010

Volltextzugriff (PDF)

CHAPTER 11 - CCR1

Anti-Inflammatory Drug Discovery, 2012, p.329-349

2012

Volltextzugriff (PDF)

To Market, To Market—2012

Annual Reports in Medicinal Chemistry, 2013, Vol.48, p.471-546

2013

Volltextzugriff (PDF)

n-Pentenyl glycoside methodology for rapid assembly of homoglycans exemplified with the nonasaccharide component of a high-mannose glycoprotein

Journal of the American Chemical Society, 1992-10, Vol.114 (21), p.8334-8336

1992

Volltextzugriff (PDF)

The chemistry of N-pentenyl glycosides: Synthetic, theoretical, and mechanistic ramifications

Pure and applied chemistry, 1993-01, Vol.65 (4), p.779-786

1993

Volltextzugriff (PDF)

Methods for Debrominating 4,5-Dibromopentanyl Glycosides

Journal of carbohydrate chemistry, 1996-01, Vol.15 (1), p.65-72

1996

Volltextzugriff (PDF)

Synthesis and Structure-Activity Relationships of 3,4-Diaminocyclobut-3-ene-1,2-dione CXCR2 Antagonists

ChemInform, 2006-11, Vol.37 (47), p.no-no

2006

Volltextzugriff (PDF)

Chemokine Receptors as Drug Targets. Edited by Martine J. Smit, Sergio A. Lira and Rob Leurs

ChemMedChem, 2011, Vol.6 (8), p.1530-1530

Merritt, J. Robert

2011

Volltextzugriff (PDF)

Building optimism: An outlook for the construction market shows confidence

Business credit, 1998-07, Vol.100 (7), p.55

Merritt, Robert J

1998

Volltextzugriff (PDF)

1 – 25 von 517

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(463)
Mit Volltextzugriff
(419)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

CC chemokine receptor small molecule antagonists in the treatment of rheumatoid arthritis and other diseases: a current view

Small molecule chemokine mimetics suggest a molecular basis for the observation that CXCL10 and CXCL11 are allosteric ligands of CXCR3

Discovery of 2-Hydroxy-N,N-dimethyl-3-{2-[[(R)-1-(5- methylfuran-2-yl)propyl]amino]-3,4-dioxocyclobut-1-enylamino}benzamide (SCH 527123): A Potent, Orally Bioavailable CXCR2/CXCR1 Receptor Antagonist

Identification of CXCR3 receptor agonists in combinatorial small-molecule libraries

3,4-Diamino-2,5-thiadiazole-1-oxides as potent CXCR2/CXCR1 antagonists

Synthesis and structure–activity relationships of new disubstituted phenyl-containing 3,4-diamino-3-cyclobutene-1,2-diones as CXCR2 receptor antagonists

Chemokine receptors as targets in medicinal chemistry and drug discovery

C(4)-alkyl substituted furanyl cyclobutenediones as potent, orally bioavailable CXCR2 and CXCR1 receptor antagonists

Novel Pyrrolidine Ureas as C−C Chemokine Receptor 1 (CCR1) Antagonists

Synthesis and structure–activity relationships of 3,4-diaminocyclobut-3-ene-1,2-dione CXCR2 antagonists

To Market, To Market—2013

Novel pyrrolidine heterocycles as CCR1 antagonists

Synthesis and structure–activity relationships of heteroaryl substituted-3,4-diamino-3-cyclobut-3-ene-1,2-dione CXCR2/CXCR1 receptor antagonists

Diaminocyclobutenediones as potent and orally bioavailable CXCR2 receptor antagonists: SAR in the phenolic amide region

n-Pentenyl Glycosides in Organic Chemistry: A Contemporary Example of Serendipity

n-Pentenyl Mannoside Precursors for Synthesis of the Nonamannan Component of High Mannose Glycoproteins

Editorial [Hot topic: Chemokine Receptors as Targets in Medicinal Chemistry and Drug Discovery (Guest Editors: J. Robert Merritt and Maria Webb)]

CHAPTER 11 - CCR1

To Market, To Market—2012

n-Pentenyl glycoside methodology for rapid assembly of homoglycans exemplified with the nonasaccharide component of a high-mannose glycoprotein

The chemistry of N-pentenyl glycosides: Synthetic, theoretical, and mechanistic ramifications

Methods for Debrominating 4,5-Dibromopentanyl Glycosides

Synthesis and Structure-Activity Relationships of 3,4-Diaminocyclobut-3-ene-1,2-dione CXCR2 Antagonists

Chemokine Receptors as Drug Targets. Edited by Martine J. Smit, Sergio A. Lira and Rob Leurs

Building optimism: An outlook for the construction market shows confidence

Suchergebnisse filtern